Evaluation of an 8-week Behavior Skills-based Virtual Reality Program for Adolescents With Depression. (MDD) (MDD)

Evaluation of an 8-week Behavior Skills-based Virtual Reality Program for Adolescents With Depression

Evaluation of an 8-week Behavior Skills-based Virtual Reality Program for Adolescents With Depression.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Evaluation of an 8-week Behavior Skills-based Virtual Reality Program for Adolescents With Depression. The Program Enrolls Children With Diagnosis of Major Depressive Disorder, Through Use of Virtual Reality and Education, We Are Measuring Effectiveness of the Program Through Use of PHQ9-A and GAD7. (MDD)

Study Type

Interventional

Enrollment (Estimated)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

-

Exclusion Criteria:

  • A patient that has been started on an antidepressant medication within the last 8 weeks.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 10 adolescents with diagnosis of depression
This is a single arm study for effectiveness. 10 adolescents will be enrolled in first study.
We will use a combination of virtual reality experiences and educational experiences.
Other Names:
  • Educational platform

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Virtual Reality use helps teens with depression
Time Frame: 8 weeks
Using PHQ9 scores, does this program help improve their depression scores?
8 weeks
Virtual Reality use helps teens with anxiety
Time Frame: 8 weeks
Using GAD7 scores, does this program help improve their anxiety scores?
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lindsey Van Duyn, DO, Edward Via College of Osteopathic Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

January 1, 2027

Study Registration Dates

First Submitted

September 2, 2026

First Submitted That Met QC Criteria

September 2, 2026

First Posted (Actual)

September 8, 2026

Study Record Updates

Last Update Posted (Actual)

September 8, 2026

Last Update Submitted That Met QC Criteria

September 2, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2270964

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe